Pete Sessions (R-TX)
Homeopathic Drug Product Safety, Quality, and Transparency Act
A Republican bill with 1 Democratic cosponsor · See all 6 cosponsors
Last activity — Referred to the House Committee on Energy and Commerce.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill, titled the "Homeopathic Drug Product Safety, Quality, and Transparency Act," seeks to amend the Federal Food, Drug, and Cosmetic Act. It aims to create a specific statutory pathway for the regulation of homeopathic drug products to ensure continued consumer and practitioner access. The legislation establishes new definitions for homeopathic ingredients and drug products. It also sets requirements for safety, quality, and transparency to prevent regulatory barriers. Additionally, the bill mandates the creation of a Homeopathic Drug Product Advisory Committee to advise the Secretary. Finally, it withdraws existing FDA guidance regarding these products.
Yes· 3 of 5
- Scored +6
Does this make health care easier to get in general?
The bill aims to ensure continued consumer and practitioner access to homeopathic drug products by reducing regulatory barriers.
- Scored +5
Does this make what the government does easier for the public to see?
The bill requires manufacturers to disclose the source of their indications and provides a mechanism for the Secretary to publish safe levels in the Federal Register.
- Scored +5
Does this make it easier to run a small business?
The bill creates a specific statutory pathway for homeopathic products that reduces the risk of sudden regulatory barriers for manufacturers.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Ensuring Access to Products: The Act seeks to address the needs of consumers and practitioners for continued access to homeopathic drug products (Section 2).
-
Reducing Regulatory Barriers: The bill aims to prevent federal agencies from imposing regulatory barriers that could unreasonably limit access to safe products and accurate information (Section 2).
-
Standardized Safety and Quality: Homeopathic products would be subject to safety and quality standards found in the Homeopathic Pharmacopoeia of the United States or other accredited voluntary consensus standards (Section 4).
-
Clearer Labeling for Consumers: For retail sale, labels would be required to include purposes or indications for use supported by various sources, such as traditional homeopathic references or peer-reviewed medical journals (Section 4).
-
Expert Oversight: The establishment of a Homeopathic Drug Product Advisory Committee ensures that a group of experts, including manufacturers, practitioners, and consumers, can advise the Secretary on regulation (Section 4).
Potential Negative Impacts for People
-
Mandatory Testing for High-Risk Materials: Manufacturers of products using starting materials that may present a substantial risk of illness or injury in undiluted form must ensure and document that the substance does not exceed a specific safe level (Section 4).
-
New Labeling Requirements: Products intended for retail sale must include specific statements noting that indications have not been evaluated by the Food and Drug Administration (Section 4).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Governance And Ideology
- Does this make what the government does easier for the public to see? — The bill requires manufacturers to disclose the source of their indications and provides a mechanism for the Secretary to publish safe levels in the Federal Register. Does this leave more decisions to the states? — The bill explicitly states that it shall not preempt or interfere with State jurisdiction concerning the practice of homeopathy.
- Economy And Finance
- Does this make it easier to run a small business? — The bill creates a specific statutory pathway for homeopathic products that reduces the risk of sudden regulatory barriers for manufacturers. Does this give people more protection from unfair business practices? — The bill mandates specific labeling requirements for retail products and requires documentation of safety levels for high-risk materials.
- Healthcare
- Does this make health care easier to get in general? — The bill aims to ensure continued consumer and practitioner access to homeopathic drug products by reducing regulatory barriers.
- 7/20/2026
- 2 Cosponsors added.
- 5/20/2026
- 1 Cosponsor added.
- 4/21/2026
- 1 Cosponsor added.
- 1/14/2026
- Referred to the House Committee on Energy and Commerce.
- 2 Cosponsors added.
- Introduced in House
Michael CloudRepublican · Texas
Paul GosarRepublican · Arizona
Jonathan JacksonDemocrat · Illinois
Mike KennedyRepublican · Utah
Cory MillsRepublican · Florida
Burgess OwensRepublican · Utah